A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2015
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms HIV
- Sponsors Gilead Sciences
- 30 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Feb 2014 Planned End Date changed from 22 Jun 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 06 Mar 2013 New trial record